Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Distribution Agreement

13 Oct 2009 07:00

RNS Number : 6499A
Ultima Networks PLC
13 October 2009
 



13 October 2009

ULTIMA NETWORKS Plc ("Ultima")

Distribution Agreement with Makro UK

Ultima Networks Plcthe AIM listed green technology company, is pleased to announce that its Electric Bicycle Division has entered into an agreement with Makro UK to supply it with Ultima's range of electric cycles. Makro UK is a major cash and carry wholesaler operating in the UK. Initially, 27 Makro UK stores across the country will sell Ultima's high quality, mid-range PowaCycle Salisbury LPX, and Ultima expects other electric bicycle models  to be introduced in the near future.

Makro UK is part of the Metro Group, the world's cash & carry leader, which has over 600 stores in 30 countries. It sells a wide selection of goods tailored specially to the needs of its many thousands of retail and wholesale customers.

Wassim Mughal, MD of Electric Bicycle Division, commented: "The PowerCycle Salisbury LPX is one of the most popular electric bicycles ever to be sold in the UK. We are confident that its sales will be even more buoyant now that it is being offered by Makro - our first national chain of stores."

ends

Contact:

Ultima Networks Plc

Humayun Mughal, CEO Ultima Networks plc 01279 821 200

Allenby Capital Limited

Nick Naylor/Nick Athanas 0203 328 5661

Threadneedle Communications

Graham Herring/Alex White 020 7653 9850

About Ultima Networks Plc

Ultima operates three divisions:

 IT and related services -  develops and supplies computer-based application software and services to the legal profession
Green Technology  responsible for the design, development and distribution of electric bicycles and other green technology products
Green Power -  involved in the development of solar power parks in Italy andSpain

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUURBRKORRAAA
Date   Source Headline
17th Mar 202612:14 pmRNSResult of General Meeting and Change of Name
27th Feb 20267:00 amRNSNotice of GM and Proposed Change of Name
24th Feb 20267:00 amRNSCEO Appointment & Name Change Thalia Therapeutics
17th Dec 20257:00 amRNSBusiness and Operational Update
25th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSPartnership with University of Strathclyde’s CMAC
22nd Sep 20257:00 amRNSN4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
11th Sep 20257:00 amRNS-RInvestor Event and Presentation
30th Jul 20251:55 pmRNS-RArticle on Nuvec®’s Potential in RNA Therapeutics
14th Jul 20257:00 amRNS-RInvestor Webinar
8th Jul 20257:00 amRNSDirectorate Change
30th Jun 20252:15 pmRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
25th Jun 20257:00 amRNS-RInsight Event for Retail Investors
6th Jun 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
27th May 20257:00 amRNS-REstablishment of New Senior Leadership Team
23rd May 202512:37 pmRNSTR-1: Notification of major holdings
21st May 20254:11 pmRNSHolding(s) in Company
15th May 20253:13 pmRNSChange of Registered Address
12th May 20257:00 amRNSN4 101 In Vivo Study Results
9th May 20258:24 amRNSHolding(s) in Company
29th Apr 20254:25 pmRNSHolding(s) in Company
29th Apr 202511:05 amRNSHolding(s) in Company
28th Apr 20252:30 pmRNSHolding(s) in Company
23rd Apr 20252:32 pmRNSTR-1: Standard form notification of major holdings
22nd Apr 202511:56 amRNSResult of General Meeting
4th Apr 20257:08 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20254:08 pmRNSPlacing and Subscription to raise £1,750,000
18th Feb 202512:34 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNS-RInvestor Webinar
27th Jan 20257:00 amRNS-RInvestor Webinar
16th Jan 20257:00 amRNS-RN4 Pharma Non-Executive Director Q&A
8th Jan 20257:00 amRNSDirectorate Changes
12th Dec 20247:00 amRNSN4 101 In Vitro Results
4th Dec 20247:00 amRNSNew Patent Filing
28th Nov 20247:00 amRNSGrant of Options
24th Sep 20247:00 amRNSInterim Results
17th Sep 20248:04 amRNSSRI Research Update
9th Sep 20247:00 amRNSDirector Appointment
23rd Aug 20248:30 amRNSChange of Auditor
20th Aug 20247:00 amRNSSRI Research Update
3rd Jul 20247:00 amRNSNanogenics Update
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.